Navigation Links
Government of Canada supports scientific research to deepen knowledge of H1N1 flu virus
Date:10/14/2009

This press release is available in French.

Winnipeg (October 14, 2009) The Government of Canada through the Canadian Institutes of Health Research (CIHR) today announced support for five new research projects designed to help further understand and address the H1N1 flu virus.

"Canada is a global leader in H1N1 flu virus research, including research with our international partners on a safe and effective H1N1 vaccine," said Health Minister Leona Aglukkaq. "The scientific research we are funding today will help ensure that our knowledge, approach and planning remain among the best in the world."

The research announced today a total $2.4 million over 2 years - is being funded through CIHR's Catalyst Grant program, which provides short-term funding for targeted health research activities. The projects were selected through a rigorous, independent peer review process following a call for applications issued in July 2009.

"In terms of research into the H1N1 flu virus, Canada and the international community have come a long way in a short time. However, important questions remain," said Dr. Alain Beaudet, President of CIHR. "The funding announced today will help ensure that Canada continues to contribute to the body of H1N1 knowledge in areas such as immunity and health care response."

The five research projects announced today are:

  • Dr. Robert Fowler at Sunnybrook Health Sciences Centre in Toronto will lead a team of researchers studying how to best manage health-care resources during a pandemic. His work will focus on determining who is most likely to get sick and how can institutions better prepare to help them.

  • Dr. Allison McGeer from Mount Sinai Hospital in Toronto and her team will be studying the impact of H1N1 on pregnant women. This will include looking at the best ways to reduce infection and why only some pregnant women develop complications.

  • Dr. John Schrader from the University of British Columbia and his team will look into the rapid development of new drug therapies to treat patients with severe H1N1 infections.

  • Dr. Satyendra Sharma from the University of Manitoba and his team will seek to determine why some patients with H1N1 go on to develop Serious Respiratory Illness. The team will closely study how the immune system fights the virus, and how this response differs in persons who develop severe illness after being infected with H1N1. The team will also track the long-term outcome of people who have developed Severe Respiratory Illness.

  • Dr. Ccile Tremblay from the Centre hospitalier de l'Universit de Montral and her team will look at various immune responses to the vaccine with a view to develop immune-based preventative and therapeutic strategies for those at a higher risk of severe illness.

This research builds on the work being done by the Public Health Agency of Canada and the CIHR Influenza Research Network.


'/>"/>

Contact: David Coulombe
david.coulombe@cihr-irsc.gc.ca
613-941-4563
Canadian Institutes of Health Research
Source:Eurekalert

Related medicine news :

1. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
2. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
3. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
4. Canadas government funds $1.6M in modern geography to support public health decisions
5. AMERIGROUP Contracts with Federal Government to Offer Medicare Advantage Health Plans in Seven States
6. Cancer Doctors Across America Stunned at Governments Ruling Restricting Anemia Management Protocols for Cancer Patients, Call Ruling Interference in Practice of Medicine
7. UCLA to lead local study center in landmark government study of child health
8. Government of Madagascar and Coalition of Global Partners Launch Measles and Malaria Prevention Campaign
9. CHRI Receives Approval for Suining Chuan DAR Authentication Trademark From Chinese Government
10. Leading Oncologists from Across the Country Hold Emergency Meeting on New Government Reimbursement Policy for Medicare Patients with Cancer
11. Government restrictions on weight loss surgeries limit access for poor, underinsured patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... 2017 , ... Steviva Ingredients, makers of all-natural sweeteners and ... Organic Program (NOP) for its Portland SQF Level 2 manufacturing facility. , ... systems to complement our current rigorous food-safety management systems,” said Yishu Hou, quality ...
(Date:1/23/2017)... ... ... a story of love and redemption, hope and uncertainty as a girl makes her way ... at the Mill” is the creation of published author, Lois Kulp, who was born in ... County on Crow Hill. The inn, the mill and "Post Yokel" are within ...
(Date:1/23/2017)... ... 23, 2017 , ... Valentine’s Day is a time when many people celebrate romance and love ... may be looking for the ideal present, Atlanta-based Perimeter Plastic Surgery is offering ... free. Or, spend $200 and get $50 free. , “A lot of people just ...
(Date:1/21/2017)... Boca Raton, FL (PRWEB) , ... January 21, 2017 , ... ... Bump eRaiser, recently attended the January ECRM Trade Show in Hilton Head, SC, where ... an international reputation for the quality of its beauty and wellness products. At this ...
(Date:1/21/2017)... ... January 21, 2017 , ... Pacifica Graduate Institute’s Alumni ... line-up of events for its annual meeting “Coming Home 2017,” an activity-packed weekend ... Home 2017” will be held on Friday January 27 through Sunday, January 29, ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... According to a new market research report ... Compliance, SCM), Component (Software, Service), Delivery (On premise, Cloud), End user ... MarketsandMarkets, the market is expected to reach USD 24.73 Billion by ... 13.3% during the forecast period. Continue ... ...
(Date:1/21/2017)... Jan. 20, 2017  Today, during a ... "PI3K Pathways in Immunology, Growth Disorders and ... INFI ) presented preclinical data ... that selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma). Preclinical data ... overcome resistance to checkpoint inhibition by remodeling ...
(Date:1/21/2017)... , Jan. 20, 2017  Faruqi & Faruqi, LLP, ... Inc. ("KemPharm" or the "Company") (NASDAQ: KMPH ) ... Company and certain officers and directors and underwriters of the ... seek the role of lead plaintiff. The lawsuit ... District Court for Johnson County on ...
Breaking Medicine Technology: